Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Rollover Study in Chronic Hepatitis B
NCT00975091Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
Phase 3, open-label trial of entecavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Number and percentage of subjects with adverse events, laboratory abnormalities, and discontinuations due to adverse events. Started May 2004; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00975091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975091.